Reuben Guttman is a founding member of Guttman Buschner LLP and a mediator with Resolute Systems, where he brings decades of complex litigation experience to dispute resolution. Having litigated and tried cases involving fraud, breach of fiduciary duty, antitrust, environmental claims, and other statutory and common law violations, he offers mediating parties a seasoned perspective on the full arc of complex litigation — from investigation and discovery through trial and settlement. Called “one of the world’s most prominent whistleblower attorneys” by the International Business Times and a “Health Care MVP” by Law 360, he has built a career recovering billions of dollars on behalf of whistleblowers and the federal government.
Guttman’s FCA recoveries rank among the largest in the statute’s history. He represented whistleblowers in Pfizer’s $2.3 billion settlement in 2009, GlaxoSmithKline’s $3 billion settlement in 2012, and Abbott Laboratories’ $1.6 billion Depakote settlement that same year. He also represented Lynn Szymoniak, whose mortgage fraud qui tam case contributed to the government’s landmark $25 billion settlement with major banks, and served as lead counsel in the 2013 Rapamune case resulting in a $491 million Pfizer settlement.
Guttman is also an Adjunct Professorial Instructor at American University, a current faculty member of the National Institute of Trial Advocacy, and a Fellow of the American Bar Foundation. He is admitted to practice before the Supreme Court of the United States and multiple federal circuits and district courts.
More information about Mr. Guttman’s mediation services is available at https://reubenguttmanmediation.com/.
